Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viemed Healthcare (VMD) Amortization of Deferred Charges (2024 - 2025)

Viemed Healthcare's Amortization of Deferred Charges history spans 2 years, with the latest figure at $107000.0 for Q4 2025.

  • For Q4 2025, Amortization of Deferred Charges rose 105.77% year-over-year to $107000.0; the TTM value through Dec 2025 reached $228000.0, up 21.93%, while the annual FY2025 figure was $228000.0, 21.93% up from the prior year.
  • Amortization of Deferred Charges reached $107000.0 in Q4 2025 per VMD's latest filing, up from $57000.0 in the prior quarter.
  • In the past five years, Amortization of Deferred Charges ranged from a high of $107000.0 in Q4 2025 to a low of $29000.0 in Q2 2025.